RecruitingNCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
PHASE2 · PHASE3 · 960 planned enrolment
- Countries listed
- 12
- Registry update
- October 2, 2026
Source-linked trial list
The registrations behind this number.
Verify the exact trial registrations behind a company, intervention, programme or topic count.
Exact trial list
2 matching trial registrations
- Company EyeBiotech Ltd.
Showing 1–2 of 2. Every record below meets all the filters shown above.
CompletedNCT05919693
A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD)
PHASE1 · PHASE2 · 33 planned enrolment
- Countries listed
- 4
- Registry update
- September 29, 2026